**Core Concept**
Bladder exstrophy is a congenital anomaly characterized by the failure of the bladder to close during embryonic development, leading to its exposure through the abdominal wall. In this condition, the child may also have associated renal anomalies, which can contribute to chronic renal failure. The choice of muscle relaxant is critical in this scenario, as it must not exacerbate the underlying renal dysfunction.

**Why the Correct Answer is Right**
The correct answer is Rocuronium, a non-depolarizing neuromuscular blocker. This choice is preferred in patients with renal impairment because it is primarily eliminated by the liver, whereas other muscle relaxants like Vecuronium may be affected by renal excretion. Rocuronium has a shorter onset time and can be easily titrated to achieve the desired degree of muscle relaxation, which is essential during complex surgical procedures.

**Why Each Wrong Option is Incorrect**
**Option A:** Vecuronium - While a commonly used muscle relaxant, Vecuronium is primarily excreted through the kidneys, which can lead to accumulation and prolongation of its effects in patients with renal failure.
**Option B:** Pancuronium - This long-acting non-depolarizing neuromuscular blocker is contraindicated in patients with renal impairment due to its significant renal excretion and potential for accumulation.
**Option C:** Succinylcholine - A depolarizing muscle relaxant that can cause a significant increase in potassium levels, which can be dangerous in patients with renal failure and electrolyte imbalances.

**Clinical Pearl / High-Yield Fact**
When choosing a muscle relaxant in patients with renal impairment, it is essential to consider the pharmacokinetics of the agent, including its elimination pathway, to minimize the risk of accumulation and adverse effects.

**Correct Answer:** C. Rocuronium.